HUTCHINSON, Minn., March 7, 2011 (GLOBE NEWSWIRE) -- Hutchinson Technology Incorporated (Nasdaq:HTCH) today announced that it has received 510(k) clearance of the InSpectra™ StO2 Spot Check from the U.S. Food and Drug Administration. The product, which is targeted for use in emergency and critical care environments, is a cost-effective tool to help rapidly assess tissue perfusion and shock.
About Hutchinson TechnologyHutchinson Technology is a global technology manufacturer committed to creating value by developing solutions to critical customer problems. The company's BioMeasurement Division is focused on bringing new technologies and products to the market that provide information clinicians can use to improve the quality of health care and reduce costs. The company's Disk Drive Components Division is a key worldwide supplier of suspension assemblies for disk drives. Cautionary Note Regarding Forward-Looking Statements This announcement may include forward-looking statements, including statements regarding marketing clearance by regulatory bodies and product commercialization and adoption. The company does not undertake to update its forward-looking statements. These statements involve risks and uncertainties. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of changes in timely clearance by the appropriate regulatory bodies, market acceptance of new products and other factors described from time to time in the company's reports filed with the Securities and Exchange Commission.
CONTACT: Investor Contact: Chuck Ives Hutchinson Technology Inc. 320-587-1605 Media Contact: Connie Pautz Hutchinson Technology Inc. 320-587-1823